Skip to main content

Guaifenesin and Dextromethorphan HBr

NDC 71179-011 · VESPYR BRANDS LLC

Generic nameGuaifenesin and Dextromethorphan HBr
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE
Strength60; 1200 mg/1; mg/1
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryANDA

Packages

71179-011-21 — 3 BLISTER PACK in 1 CARTON (71179-011-21) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

70692-181 — Dextromethorphan Hydrobromide, Guaifenesin, 70692-778 — Dextromethorphan hydrobromide, 70692-836 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, 70692-837 — Acetaminophen, Dextromethorphan hydrobromide, Doxylamine succinate, Phenylephrine hydrochloride, 70893-0011 — DEXTROMETHORPHAN HYDROBROMIDE, 70893-0012 — DEXTROMETHORPHAN HYDROBROMIDE, 71141-179 — Acetaminophen, Dextromethorphan HBr, Phenylephrine HCl, 71141-180 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 71179-002 — Guaifenesin, 71179-003 — Acetaminophen, Dextromethorphan hydrobromide and Doxylamine Succinate, 71205-624 — Codeine Phosphate and Guaifenesin, 71205-654 — Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution, 71309-461 — GUAIFENESIN, 71335-1035 — Guaifenesin, 71335-1928 — Guaifenesin and Dextromethorphan HBr, 71335-2032 — Guaifenesin, 71335-2216 — Dextromethorphan Hydrobromide / Guaifenesin, 71335-2642 — Guaifenesin, 71335-9616 — Guaifenesin, 71399-0024 — Guaifenesin, +2508 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels